Broker wrap: the outlook for 3 key ASX 200 stocks
With local equity markets entering fresh bull territory last Thursday, we examine what some of Australia’s top brokers are saying about three key ASX 200 stocks.
Treasury Wine Estates share price: a spin-off in focus
Australia’s iconic $7.6 billion wine company – Treasury Wine Estates – this week announced details around a potential spin-off of its luxury Penfolds brand. Though the stock was initially bid higher off the back of this news, enthusiasm soon waned, with the stock finishing the week flat.
Citi analysts said they couldn’t ‘see sufficient value creation’ from the potential demerger; while Credit Suisse described the basic idea behind the spin-off as not being compelling; and Macquarie said that though the Penfolds brand is indeed valuable, ‘it is difficult to see the strategic appeal in New TWE.’
This scepticism was well reflected in the price targets of the respective brokers: Citi has a price target of $11.05 per share on TWE; while Macquarie has a 12-month price target of just $9.50 per share on the wine maker. Illustrating just how much sentiment has changed for the stock: in September 2019 Macquarie pegged TWE’s fair value at $19.97 per share.
Credit Suisse has a price target of $10.61 on Treasury.
CBA share price: can the dividend be saved?
The outlook for the big four banks became more complex this week, with APRA telling Australia’s authorised deposit taking institutions (ADIs) that due to the current economic outlook, they should limit discretionary capital expenditure in the months ahead.
The analyst response was mostly a bearish one: Macquarie said that under a stressed scenerio ANZ, Westpac (WBC) and NAB would likely have to suspend their upcoming dividends, while CBA ‘should still be able to sustain a reduced dividend.'
UBS took a similar line – slashing the interim dividend outlook for ANZ, Westpac and NAB to zero – while keeping CBA’s 2H dividend forecast at $1.60 per share.
Citibank, by comparison, remained bullish on the big four’s prospects – even in the face of APRA’s latest capital directives – retaining its Buy ratings on ANZ, CBA, Westpac and NAB.
The below table breaks down the 12-month price targets (PT) on the banks from UBS, Citibank and Macquarie:
Flight Centre share price: the cost of doing business
Following the completion of the institutional portion of Flight Centre’s planned equity raise – which saw the company raise ~$562 million; optimism, at least on a short-term basis, looks to have improved for the beleaguered company. On Tuesday the Flight Centre share price gained 0.8%, on Wednesday 6.1% and on Thursday 9.05%, to finish out the week at $11.560 per share.
Some of Australia’s top brokers also look to be cautiously optimistic on FLT’s prospects.
Indeed, Morgans took a positive view in the wake of this equity raise, saying that at current price levels and with Flight Centre’s now strengthened liquidity position, there may be upside potential for prospective investors. In step with that, Morgans upgraded its recommendation on FLT to Add, and hit the stock with a price target of $13.00 per share.
Interestingly, Morgan Stanley this week retained its Overweight rating and $42.00 price target on Flight Centre, saying that ‘Post raising and debt facility funding, FLT should have an ~18 month liquidity buffer assuming zero revenue.’
Citibank was also looking for post raise positives, too; retaining their Buy rating but lowering their price target on the stock to $12.50 per share. The investment bank noted that FLT's balance sheet risk has now been removed.
Of course, staying in business in times of financial stress can be a costly enterprise. On that front, Citi analysts, speaking to the consequences of this fresh cap raise, said:
‘This comes at significant dilution for equity holders, but does enable investors to now look through the near-term cash burn to a more normalised environment in FY23e.’
Practise trading indices, currencies and equities with an IG demo account now. Click here to find out how.
This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.
Act on share opportunities today
Go long or short on thousands of international stocks with CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Try a risk-free trade
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets